|
|
||||||||
J Thorac Cardiovasc Surg 2007;133:1419-1427
© 2007 The American Association for Thoracic Surgery
General Thoracic Surgery |
a Thoracic Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY
b Division of Nuclear Medicine, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY
c Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY.
Read at the Eighty-sixth Annual Meeting of The American Association for Thoracic Surgery, Philadelphia, Pa, April 29-May 3, 2006.
Received for publication June 29, 2006; revisions received December 6, 2006; accepted for publication January 8, 2007. * Address for reprints: Robert J. Downey, MD, Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021. (Email: downeyr{at}mskcc.org).
Objectives: Positron emission tomographic maximal standardized uptake value has been shown to predict survival after resection of nonsmall cell lung cancer. The relative prognostic benefit of maximal standardized uptake value with respect to other clinical/pathologic variables has not been defined.
Methods: We reviewed patients who had positron emission tomographic imaging and an R0 resection for nonsmall cell lung cancer between January 1, 2000, and December 31, 2004, without induction or adjuvant therapy. The associations between overall survival, histology, pathologic TNM stage, pathologic tumor diameter, and standardized uptake value were tested.
Results: Four hundred eighty-seven patients met the study criteria. Median follow-up was 25.8 months. By using the median values for tumor size (2.5 cm) and standardized uptake value (5.3), standardized uptake value was an independent predictor of survival (P = .03), adjusting for tumor size (P = .02) and histology (P < .01). The optimal standardized uptake value for stratification was identified as 4.4, and this value was identified as an independent predictor of survival (P = .03) after adjusting for clinical TNM stage. Standardized uptake value was not an independent predictor of survival (P = .09), adjusting for pathologic TNM stage (stage IA vs IB vs stage IIIV, P < .01).
Conclusions: Standardized uptake value does not add to the prognostic significance of pathologic TNM stage. Standardized uptake value was an independent prognostic factor from clinical TNM stage.
Related Article
J. Thorac. Cardiovasc. Surg. 2007 133: 1425-1427.
This article has been cited by other articles:
![]() |
N. Kanauchi, H. Oizumi, T. Honma, H. Kato, M. Endo, J. Suzuki, K. Fukaya, and M. Sadahiro Role of diffusion-weighted magnetic resonance imaging for predicting of tumor invasiveness for clinical stage IA non-small cell lung cancer Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 706 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Chong Re: Prognostic value of FDG uptake in early stage non-small cell lung cancer Eur. J. Cardiothorac. Surg., October 1, 2008; 34(4): 932 - 932. [Full Text] [PDF] |
||||
![]() |
A. J. Poncelet, M. Lonneux, and F.-X. Hanin Reply to Chong Eur. J. Cardiothorac. Surg., October 1, 2008; 34(4): 932 - 933. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |